Company: TELO
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021496
Chunk: 34

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 34
---
 under this “Item 1A. Risk Factors” is not required to be presented.

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item
3. Defaults upon Senior Securities.

None.

Item
4. Mine Safety Disclosures.

Not
applicable.

Item
5. Other Information.

Not
applicable.

Item
6. Exhibits.

    Number
     
    Description

    31.1*
     
    Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

    31.2*
     
    Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

    32.1*
     
    Certification of Principal Executive Officer and Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    32.2*
     
    Certification of Principal Financial Officer and Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    101.SCH*
     
    Inline
    XBRL Taxonomy Extension Schema

    101.CAL*
     
    Inline
    XBRL Taxonomy Extension Calculation Linkbase

    101.DEF*
     
    Inline
    XBRL Taxonomy Extension Definition Linkbase

    101.LAB*
     
    Inline
    XBRL Taxonomy Extension Label Linkbase

    101.PRE*
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase

    104*
     
    Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

    *
    Furnished
    herewith

    ^
    Previously
    filed.

    +
    Denotes
    management contract or compensatory plan or arrangement.

21

SIGNATURES

Pursuant
to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

    TELOMIR
    PHARMACEUTICALS,